Get started
Author

Gilda Lemos

Observed names: G. Lemos, Gilda Lemos Pérez, Gilda Lemos-Pérez, Gilda Lemos‐Pérez, Lemos Pérez, Gilda
ORCID: 0000-0003-0596-6501
Observed ORCID: 0000-0003-0596-6501
OpenAlex ID: A5075457268
Safety, Tolerability, and Immunogenicity of a SARS-CoV-2 Recombinant Spike RBD Protein Vaccine: A Randomised, Double-Blind, Placebo-Controlled, Phase 1-2 Clinical Trial (ABDALA Study)
2022 · Francisco Hernández-Bernal, Maria C. Ricardo-Cobas, et al. · EClinicalMedicine · 70
PDF
An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
2022 · Miladys Limonta-Fernández, Glay Chinea-Santiago, et al. · New Biotechnology · 69
Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998–2003
2008 · Licel de los Angeles Rodríguez Lay, Ariel Quintana, et al. · Journal of Medical Virology · 50
Diagnosis of Dengue Virus Infection by the Visual and Simple AuBioDOT Immunoglobulin M Capture System
2003 · Susana Vázquez, Gilda Lemos, et al. · Clinical and Vaccine Immunology · 26
Hepatitis E virus in Cuba
2000 · Gilda Lemos, Shahid Jameel, et al. · Journal of Clinical Virology · 20
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice
2022 · Laura Lazo, Monica Bequet-Romero, et al. · Vaccine · 15
PDF
HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis
2021 · JC Aguilar, Jorge Aguiar, et al. · Euroasian Journal of Hepato-Gastroenterology · 13
Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis
2023 · Viviana Falcón-Cama, Teresita Montero-González, et al. · Archives of Virology · 12
PDF
Elevated Antibody Titers in Abdala Vaccinees Evaluated by Elecsys® Anti-SARS-Cov-2 S Highly Correlate with UMELISA SARS-Cov-2 ANTI RBD, ACE-2 Binding Inhibition and Viral Neutralization Assays
2022 · Gilda Lemos-Pérez, Sheila Chávez-Valdés, et al. · Journal of Biotechnology and Biomedicine · 12
Immunogenicity and Safety Assessment of a SARS-CoV-2 Recombinant Spike RBD Protein Vaccine (Abdala) in Paediatric Ages 3 to 18 Years Old: A Double-Blinded, Multicentre, Randomised, Phase 1/2 Clinical Trial (ISMAELILLO Study)
2022 · Zurina Cinza-Estévez, Sonia Resik-Aguirre, et al. · EClinicalMedicine · 11
PDF
Silent celiac disease in a cohort of healthy adults
2009 · Jose Galvan, Gilda Lemos, et al. · Autoimmunity · 11
A first‐in‐class, first‐in‐human, phase I trial of CIGB ‐552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF‐κB in patients with advanced solid tumors
2021 · Maribel G. Vallespi, Braulio Mestre, et al. · International Journal of Cancer · 9
PDF
Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical Trial
2024 · Gilda Lemos-Pérez, Yinet Barrese-Pérez, et al. · Vaccines · 8
PDF
Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials
2021 · Omar R. Blanco, Dayamí Dorta, et al. · Journal of Immunological Methods · 8
PDF
A new NS3 recombinant protein shows improved antigenic properties for HCV diagnosis
2006 · Daniel O Palenzuela, Seidy Pedroso‐Santana, et al. · Biotecnología aplicada · 7
Cuban Vaccines Abdala and Mambisa Against Covid-19
2023 · G. Guillen, M. Limonta, et al. · International Journal of Infectious Diseases · 6
Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate
2022 · Ileanet Ávalos, Thailin Lao, et al. · Vaccines · 5
PDF
Evaluación de un sistema para la detección de anticuerpos contra un antígeno sintético del core del virus de hepatitis C y su prevalencia en donantes de sangre
1994 · Guillermo Padrón, Gilda Lemos, et al. · Biotecnología aplicada · 5
A sandwich ELISA for the quantification of the anticancer peptide CIGB-552 in human plasma
2024 · Nivaldo Angel Gómez Hernández, Gilda Lemos Pérez, et al. · Analytical Biochemistry · 4
Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and blood
2022 · Dania Vázquez-Blomquist, Mónica Bequet-Romero, et al. · Clinical Immunology Communications · 4
HEBERSaVax immunotherapy combined with first‐line chemotherapy in advanced ovarian cancer: Phase II CENTAURO ‐4 trial results
2025 · Francisco Hernández‐Bernal, Katty‐Hind Selman‐Housein Bernal, et al. · International Journal of Cancer · 3
PDF
Desarrollo de un ensayo ELISA sandwich para el pesquisaje de antígenos de Bordetella pertussis expresados en cultivos de células bacterianas
2015 · Gilda Lemos, Maité Delgado-Espina, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 3
Expresión y purificación de la proteína completa NS1 del virus dengue serotipo 2 a partir de un aislamiento
2013 · Gilda Lemos, Isabel Guillén, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 3
Impact of the Route and Schedule of Immunization on the Serological and Virological Response of Chronic Hepatitis B Patients Treated with HeberNasvac
2023 · Mamun Al Mahtab, JC Aguilar, et al. · Euroasian Journal of Hepato-Gastroenterology · 2
PDF
Booster with intranasal vaccine candidate Mambisa activates the expression of tissue resident memory T cell markers
2025 · Daniel Palenzuela Gardón, Diogenes Quintana Vazquez, et al. · Journal of infectious diseases. · 1
PDF
Works count: 32
Citation count: 379
H-index: 11
I10-index: 11
Year
Topic
Type